Join us on December 2nd, 6:00 – 9:00 pm, at IndieBio in San Francisco.
This event is FREE to all participants. We look forward to seeing you there!
This event is generously sponsored by:
Time: 6:00 – 9:00pm
Dr. Jenny Rooke
For over a decade, Genoa Ventures’ founder and managing director Dr. Jenny Rooke has been deploying capital at the frontiers of life sciences innovation, with a penchant for technology-fueled solutions and category-defying opportunities. Jenny got her start in venture at Fidelity Biosciences, a Cambridge-based healthcare VC, during their Fund I formation. Jenny then brought her unique toolkit of genetics domain expertise, strategic business acumen, and venture investing to the Gates Foundation, where she deployed and managed over $250M in funding in genetic engineering, diagnostics, and synthetic biology. She also played a key role in establishing the foundation’s investing function.
In 2014, Dr. Rooke began independently investing under the brand 5 Prime Ventures, financing her investments using what has become the largest life sciences syndicate on AngelList, and one of the highest-performing AngelList syndicates of any sector. Jenny founded Genoa Ventures in 2018, building on the 5 Prime Ventures track record, in order to scale a proven, differentiated investing strategy, to ensure continued access to the very best deals, and to maximize portfolio returns.
Dr. Camelia Rusu
Camelia Rusu is a Senior Director with Lam Research Corporation. In her current role she is leading the nanoString- Lam strategic collaboration to develop the Next Generation Sequencing platform. She manages a multi-disciplinary engineering team (optics, process, microfluidics) to improve flow cell efficiency, to screen and select HVM (high volume manufacture) suppliers. Camelia joined Lam Research after graduate school and has been with the company since 2000. She started as a process engineer and consistently advanced to her current position while holding various leadership positions: process etch manager, head of the 3DIC team, head of memory Dielectric Etch Product Group for Micron Global Account and Intel memory, and most recently leading the Emerging Business Engineering team. Over the years she had the opportunity to develop multiple technologies for semiconductor equipment, to implement and transfer them at worldwide customer sites, and to grow exceptional teams. Camelia received a Ph.D. in Physical Chemistry from University of Pittsburgh, Pennsylvania, USA.